PMID- 18050203 OWN - NLM STAT- MEDLINE DCOM- 20080207 LR - 20220330 IS - 0004-3591 (Print) IS - 0004-3591 (Linking) VI - 56 IP - 12 DP - 2007 Dec TI - Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. PG - 4095-103 AB - OBJECTIVE: Ligands and antagonists of the WNT pathway are linked to osteoporosis and osteoarthritis. In particular, polymorphisms in the FRZB gene, a secreted WNT antagonist, have been associated with osteoarthritis. The aim of this study was to examine cartilage and bone in Frzb(-/-) mice. METHODS: The Frzb gene in mice was inactivated using a Cre/loxP strategy. Three models of osteoarthritis were used: collagenase, papain, and methylated bovine serum albumin induced. Bone biology was studied using density measurements and microfocal computed tomography. Bone stiffness and mechanical loading-induced bone adaptation were studied by compression of the ulnae. RESULTS: Targeted deletion of the Frzb gene in mice increased articular cartilage loss during arthritis triggered by instability, enzymatic injury, or inflammation. Cartilage damage in Frzb(-/-) mice was associated with increased WNT signaling and matrix metalloproteinase 3 (MMP-3) expression and activity. Frzb(-/-) mice had increased cortical bone thickness and density, resulting in stiffer bones, as demonstrated by stress-strain relationship analyses. Moreover, Frzb(-/-) mice had an increased periosteal anabolic response to mechanical loading as compared with wild-type mice. CONCLUSION: The genetic association between osteoarthritis and FRZB polymorphisms is corroborated by increased cartilage proteoglycan loss in 3 different models of arthritis in Frzb(-/-) mice. Loss of Frzb may contribute to cartilage damage by increasing the expression and activity of MMPs, in a WNT-dependent and WNT-independent manner. FRZB deficiency also resulted in thicker cortical bone, with increased stiffness and higher cortical appositional bone formation after loading. This may contribute to the development of osteoarthritis by producing increased strain on the articular cartilage during normal locomotion but may protect against osteoporotic fractures. FAU - Lories, Rik J U AU - Lories RJ AD - Laboratory for Skeletal Development and Joint Disorders, Department of Rheumatology, University Hospitals Leuven, Katholieke Universiteit Leuven, Herestraat 49, Leuven, Belgium. FAU - Peeters, Jenny AU - Peeters J FAU - Bakker, Astrid AU - Bakker A FAU - Tylzanowski, Przemko AU - Tylzanowski P FAU - Derese, Inge AU - Derese I FAU - Schrooten, Jan AU - Schrooten J FAU - Thomas, J Terrig AU - Thomas JT FAU - Luyten, Frank P AU - Luyten FP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Arthritis Rheum JT - Arthritis and rheumatism JID - 0370605 RN - 0 (Glycoproteins) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (WD repeat containing planar cell polarity effector) RN - 0 (Wnt Proteins) RN - EC 3.4.22.2 (Papain) RN - EC 3.4.24.- (Collagenases) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM CIN - Arthritis Rheum. 2007 Dec;56(12):3881-3. PMID: 18050212 MH - Animals MH - Biomechanical Phenomena MH - Bone Density/physiology MH - Cartilage Diseases/metabolism/pathology MH - Cartilage, Articular/*metabolism/pathology MH - Collagenases MH - Disease Models, Animal MH - Femur/*metabolism/pathology MH - Glycoproteins/genetics/*metabolism MH - Homeostasis/physiology MH - Intracellular Signaling Peptides and Proteins MH - Matrix Metalloproteinase 3/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Osteoarthritis/chemically induced/*metabolism/pathology MH - Osteoporosis/metabolism/pathology MH - Papain MH - Tibia/*metabolism/pathology MH - Wnt Proteins/*metabolism EDAT- 2007/12/01 09:00 MHDA- 2008/02/08 09:00 CRDT- 2007/12/01 09:00 PHST- 2007/12/01 09:00 [pubmed] PHST- 2008/02/08 09:00 [medline] PHST- 2007/12/01 09:00 [entrez] AID - 10.1002/art.23137 [doi] PST - ppublish SO - Arthritis Rheum. 2007 Dec;56(12):4095-103. doi: 10.1002/art.23137.